B7-H1 variants

Details B7-H1 variants B7-H1 variants

2003-10-06

2008-10-07

Ouspenski, Ilia (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C435S007100

Reexamination Certificate

active

07432351

ABSTRACT:
Variant costimulatory polypeptides, nucleic acids encoding such polypeptides, and methods for using the polypeptides and nucleic acids to enhance a T cell response are provided herein.

REFERENCES:
patent: 5580756 (1996-12-01), Linsley et al.
patent: 7105328 (2006-09-01), Wood et al.
patent: 2002/0102651 (2002-08-01), Freeman et al.
patent: 2006/0153841 (2006-07-01), Freeman et al.
patent: WO 01/14556 (2001-03-01), None
Attwood T., Science 2000; 290:471-473.
Skolnick et al., Trends in Biotech. 2000; 18(1):34-39.
Metzler et al., Nature Structural Biol. 1997; 4:527-531.
Agata et al., “Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes,”International Immunology, 1996, 8:765-772.
Bajorath et al., “Molecular modeling of CD28 and three-dimensional analysis of residue conservation in the CD28/CD152 family,”J. Mol. Graph. Model., 1997, 15:135-139.
Berman et al., “The Protein Data Bank,”Nucl. Acids Res., 2000, 28:235-242.
Chambers and Allison, “Co-stimulation in T cell responses,”Curr. Opin. Immunol., 1997, 9:396-404.
Chapoval et al., “B7-H3: A costimulatory molecule for T cell activation and IFN-γ production,”Nature Immunology, 2001, 2:269-274.
Connolly, “Analytical Molecular Surface Calculation,”J. Appl. Cryst., 1983, 16:548-558.
Cristiano and Roth, “Molecular conjugates: a targeted gene delivery vector for molecular medicine,”J. Mol. Med., 1995, 73:479-486.
Dong et al., “Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion,”Nature Medicine, 2002, 8:793-800.
Dong et al., “B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion,”Nature Med., 1999, 5:1365-1369.
Engh and Huber, “Accurate Bond and Angle Parameters for X-Ray Protein Structure Refinement,”Acta Cryst., 1991, A47:392-400.
Fechteler et al., “Prediction of Protein Three-dimensional Structures in Insertion and Deletion Regions: A Procedure for Searching Data Bases of Representative Protein Fragments Using Geometric Scoring Criteria,”J. Mol. Biol., 1995, 253:114-131.
Freeman et al., “Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation,”J. Exp. Med., 192:1027-1034.
Guatelli et al., “Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication,”Proc. Natl. Acad. Sci. USA, 1990, 87:1874-1878.
Hyrup et al., “Peptide Nucleic Acids (PNA): Synthesis, Properties and Potential Applications,”Bioorgan. Med. Chem., 1996, 4:5-23.
Ikemizu et al., “Structure and Dimerization of a Soluble Form of B7-1,”Immunity, 2000, 12:51-60.
Ishida et al., “Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death,”EMBO J., 1992, 11:3887-3895.
Ishida et al., “Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues,”Immunology Letters, 2002, 84:57-62.
Krummel and Allison, “CTLA-4 Engagement Inhibits IL-2 Accumulation and Cell Cycle Progression upon Activation or Resting T Cells,”J. Exp. Med., 1996, 183:2533-2540.
Latchman et al., “PD-L2 is a second ligand for PD-1 and inhibits T cell activation,”Nature Immunology, 2001, 2:261-268.
Lenschow et al., “CD28/B7 System of T Cell Costimulation,”Annu. Rev. Immunol., 1996, 14:233-258.
Levitt, “Accurate Modeling of Protein Conformation by Automatic Segment Matching,”J. Mol. Biol., 1992, 226:507-533.
Lewis, “PCR's Competitors Are Alive and Well and Moving Rapidly Towards Commercialization,”Genetic Engineering News, 1992, vol. 12, 3 pages.
Nishimura et al., “Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor,”Immunity, 1999, 11:141-151.
Nishimura et al., “Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses,”International Immunology, 1998, 10:1563-1572.
Nishimura et al., “Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice,”Science, 2001, 291:319-322.
Ostrov et al., “Structure of Murine CTLA-4 and Its Role in Modulating T Cell Responsiveness,”Science, 2000, 290:816-819.
Penix et al., “Two Essential Regulatory Elements in the Human Interferon γ Promoter Confer Activation Specific Expression in T Cells,”J. Exp. Med., 1993, 178:1483-1496.
Ponder et al., “Tertiary Templates for Proteins—Use of Packing Criteria in the Enumeration of Allowed Sequences for Different Structural Classes,”J. Mol. Biol., 1987, 193:775-791.
Rathmell and Thompson, “The Central Effectors of Cell Death in the Immune System,”Annu. Rev. Immunol., 1999, 17:781-828.
Schwartz et al., “Structural mechanisms of costimulation,”Nature Immunology, 2002, 3:427-434.
Schwartz et al., “Structural basis for co-stimulation by the human CTLA-4/B7-2 complex,”Nature, 2001, 410:604-608.
Stamper et al., “Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses,”Nature, 2001, 410:608-611.
Summerton and Weller, “Morpholino Antisense Oligomers: Design, Preparation and Properties,”Antisense Nucleic Acid Drug Dev., 1997, 7:187-195.
Swallow et al., “B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNFα,”Immunity, 1999, 1:423-432.
Tamura et al., “B7-H1 costimulation preferentially enhances CD28-indepenent T-helper cell function,”Blood, 2001, 97:1809-1816.
Thompson et al., “cis-Acting Sequences Required for Inducible Interleukin-2 Enhancer Function Bind a Novel Ets-Related Protein, Elf-1,”Mol. Cell. Biol., 1992, 12:1043-1053.
Todd et al., “Transcription of the Interleukin 4 Gene Is Regulated by Multiple Promoter Elements,”J. Exp. Med., 1993, 177:1663-1674.
Tseng et al., “B7-DC, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells,”J. Exp. Med., 2001, 193:839-845.
Walunas et al., “CTLA-4 Ligation Blocks CD28-dependent T Cell Activation,”J. Exp. Med., 1996, 183:2541-2550.
Wang et al., “Ligand Binding Sites of Inducible Costimulator and High Avidity Mutants with Improved Function,”J. Exp. Med., 2002, 195:1033-1041.
Wang et al., “Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS,”Blood, 2000, 96:2808-2813.
Weiss, “Hot Prospect for New Gene Amplifier: Ligase chain reaction, a combination DNA amplifier and genetic screen could do for DNA diagnostics what PCR has done for basic molecular biology,”Science, 1991, 254:1292-1293.
Williams and Barclay, “The Immunoglobulin Superfamily—Domains for Cell Surface Recognition,”Ann. Rev. Immunol., 1988, 6:381-405.
Wong et al., “Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of Natural and Recombinant Proteins,”Science, 1985, 228:810-815.
Yoshinaga et al., “T-cell co-stimulation through B7RP-1 and ICOS,”Nature, 1999, 402:827-832.
Experimental data generated by a licensee of the present application.

Affiliated with

Also associated with

Rating

B7-H1 variants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with B7-H1 variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and B7-H1 variants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4016151